Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
- University of Colorado
- University of North Carolina at Chapel Hill
- University of Washington
- University of Minnesota
- Rutgers University
- SUNY University at Buffalo
- University of Michigan - Ann Arbor
- University of Pittsburgh
- King's College London
- University of California
- University of California, Los Angeles
- University of Glasgow
- University of Illinois
- University of Kentucky
- University of Pennsylvania
- University of Texas Health Science Center San Antonio
- University of Utah
- University of Vermont Medical Center
- Boston University
- Centre for Genomic Regulation
- Columbia University
- ETH Zürich
- FUNDACIO INSTITUT D'INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- George Washington University
- Heidelberg University
- Institute for Translational Medicine and Liver Disease
- Institute for Translational Medicine and Liver Disease (ITM), Inserm U1110
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- Queen Mary University of London
- Southern Illinois University - School of Medicine
- Stanford University
- The Jiang Lab, The Icahn School of Medicine at Mount Sinai
- The Ohio State University
- The University of Arizona
- The University of Iowa
- The University of North Carolina at Chapel Hill
- University of Antwerp
- University of California San Diego
- University of California, Berkeley
- University of California, San Diego
- University of Nebraska Medical Center
- University of Newcastle
- Università Campus Bio-Medico di Roma
- Yale University
- 35 more »
- « less
-
Field
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
-obstructive diseases and fibrosis therapeutic development, two areas of urgent clinical need. Multiple therapeutic modalities will be evaluated for target engagement, molecular mechanisms and therapeutic
-
fibrosis and inflammation create a microenvironment which inhibits axonal regeneration, resulting in poor neurologic recovery. To overcome this gap from bench to clinic, we have developed a basic science
Enter an email to receive alerts for fibrosis-"https:" positions